• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ID NOW COVID-19 即时检测 SARS-CoV-2 的敏感性

Sensitive on-site detection of SARS-CoV-2 by ID NOW COVID-19.

机构信息

Centre for Biological Threats and Special Pathogens - Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, Seestraße 10, 13353 Berlin, Germany.

Influenza and Other Respiratory Viruses (FG 17), Robert Koch Institute, Seestraße 10, 13353 Berlin, Germany.

出版信息

Mol Cell Probes. 2021 Aug;58:101742. doi: 10.1016/j.mcp.2021.101742. Epub 2021 May 8.

DOI:10.1016/j.mcp.2021.101742
PMID:33971264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8105142/
Abstract

Point of care detection of SARS-CoV-2 is one pillar in a containment strategy and important to break infection chains. Here we report the sensitive, specific and robust detection of SARS-CoV-2 and respective variants of concern by the ID NOW COVID-19 device.

摘要

即时检测（POC）是传染病防控策略的一个重要组成部分，对阻断感染链至关重要。在此，我们报告了 ID NOW COVID-19 设备对 SARS-CoV-2 及其相关关切变异株的灵敏、特异和稳健的检测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d987/8105142/e61395cfc8be/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d987/8105142/92863cc24d4d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d987/8105142/e61395cfc8be/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d987/8105142/92863cc24d4d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d987/8105142/e61395cfc8be/gr2_lrg.jpg

相似文献

1
Sensitive on-site detection of SARS-CoV-2 by ID NOW COVID-19.ID NOW COVID-19 即时检测 SARS-CoV-2 的敏感性
Mol Cell Probes. 2021 Aug;58:101742. doi: 10.1016/j.mcp.2021.101742. Epub 2021 May 8.
2
Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting.在低流行环境中对雅培ID NOW SARS-CoV-2快速分子检测进行多地点即时护理评估。
Pathology. 2021 Dec;53(7):912-914. doi: 10.1016/j.pathol.2021.07.002. Epub 2021 Sep 4.
3
COVID-19 and Diagnostic Testing for SARS-CoV-2 by RT-qPCR-Facts and Fallacies.COVID-19 和 SARS-CoV-2 的 RT-qPCR 诊断检测：事实与谬误。
Int J Mol Sci. 2021 Feb 28;22(5):2459. doi: 10.3390/ijms22052459.
4
Development and validation of a new triplex real-time quantitative reverse Transcriptase-PCR assay for the clinical detection of SARS-CoV-2.开发和验证一种新的三联实时荧光定量逆转录聚合酶链反应检测方法，用于 SARS-CoV-2 的临床检测。
Mol Cell Probes. 2021 Aug;58:101744. doi: 10.1016/j.mcp.2021.101744. Epub 2021 Jun 4.
5
Abbott ID now COVID-19 assay performance: a year in review.雅培ID Now新型冠状病毒检测性能：回顾一年
Diagn Microbiol Infect Dis. 2021 Dec;101(4):115536. doi: 10.1016/j.diagmicrobio.2021.115536. Epub 2021 Sep 4.
6
Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.Cepheid Xpert Xpress 和 Abbott ID NOW 检测试剂盒快速检测 SARS-CoV-2 的诊断准确性：系统评价和荟萃分析。
J Med Virol. 2021 Jul;93(7):4523-4531. doi: 10.1002/jmv.26994. Epub 2021 May 3.
7
The ID NOW COVID-19, a high-speed high-performance assay.ID NOW COVID-19，一种高速高性能检测方法。
Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):2041-2045. doi: 10.1007/s10096-021-04243-0. Epub 2021 Apr 15.
8
Experience With False-Positive Test Results on the TaqPath Real-Time Reverse Transcription-Polymerase Chain Reaction Coronavirus Disease 2019 (COVID-19) Testing Platform.TaqPath实时逆转录-聚合酶链反应2019冠状病毒病（COVID-19）检测平台假阳性检测结果的经验
Arch Pathol Lab Med. 2021 Mar 1;145(3):259-261. doi: 10.5858/arpa.2020-0612-LE.
9
RT-qPCR Diagnostics: The "Drosten" SARS-CoV-2 Assay Paradigm.实时荧光定量 RT-PCR 诊断：“多斯特恩”SARS-CoV-2 检测方法。
Int J Mol Sci. 2021 Aug 13;22(16):8702. doi: 10.3390/ijms22168702.
10
Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay.Cepheid Xpert® Xpress SARS-CoV-2 检测的样本混合。
Diagn Microbiol Infect Dis. 2021 Feb;99(2):115238. doi: 10.1016/j.diagmicrobio.2020.115238. Epub 2020 Oct 15.

引用本文的文献

1
Perspectives of physicians and medical assistants on the implementation of NAAT-based point-of-care testing for SARS-CoV-2 in primary care in Germany.德国初级保健中基于 NAAT 的即时检测 SARS-CoV-2 实施情况的医生和医疗助理观点。
Z Evid Fortbild Qual Gesundhwes. 2022 Dec;175:43-49. doi: 10.1016/j.zefq.2022.09.006. Epub 2022 Nov 10.
2
"It Was Very Comforting to Find Out Right Away." - Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care.“马上得知结果让人倍感安心。”——患者对基层医疗中即时分子SARS-CoV-2检测的看法
Patient Prefer Adherence. 2022 Aug 10;16:2031-2039. doi: 10.2147/PPA.S372366. eCollection 2022.
3

本文引用的文献

1
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原和基于分子的检测。
Cochrane Database Syst Rev. 2021 Mar 24;3(3):CD013705. doi: 10.1002/14651858.CD013705.pub2.
2
Summary of the Available Molecular Methods for Detection of SARS-CoV-2 during the Ongoing Pandemic.当前大流行期间用于检测 SARS-CoV-2 的分子方法概述。
Int J Mol Sci. 2021 Jan 28;22(3):1298. doi: 10.3390/ijms22031298.
3
Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19).
Micro/nano biomedical devices for point-of-care diagnosis of infectious respiratory diseases.
用于传染性呼吸道疾病即时诊断的微纳生物医学装置。
Med Nov Technol Devices. 2022 Jun;14:100116. doi: 10.1016/j.medntd.2022.100116. Epub 2022 Feb 12.
COVID-19 住院患者中感染性病毒排出的持续时间和关键决定因素。
Nat Commun. 2021 Jan 11;12(1):267. doi: 10.1038/s41467-020-20568-4.
4
Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay.新型 GeneXpert Xpress SARS-CoV-2 PCR 检测方法的初步验证。
J Virol Methods. 2020 Oct;284:113925. doi: 10.1016/j.jviromet.2020.113925. Epub 2020 Jul 10.
5
Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples.从诊断样本中预测传染性严重急性呼吸综合征冠状病毒 2。
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666. doi: 10.1093/cid/ciaa638.
6
Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.SARS-CoV-2 大流行期间赛沛 Xpert® Xpress SARS-CoV-2 即时检测的多中心评估。
J Clin Virol. 2020 Jul;128:104426. doi: 10.1016/j.jcv.2020.104426. Epub 2020 May 11.
7
Laboratory Diagnosis of COVID-19: Current Issues and Challenges.新型冠状病毒肺炎的实验室诊断：当前的问题和挑战。
J Clin Microbiol. 2020 May 26;58(6). doi: 10.1128/JCM.00512-20.
8
Virological assessment of hospitalized patients with COVID-2019.住院 COVID-19 患者的病毒学评估。
Nature. 2020 May;581(7809):465-469. doi: 10.1038/s41586-020-2196-x. Epub 2020 Apr 1.
9
Laboratory diagnosis of emerging human coronavirus infections - the state of the art.新型人冠状病毒感染的实验室诊断——现状。
Emerg Microbes Infect. 2020 Dec;9(1):747-756. doi: 10.1080/22221751.2020.1745095.
10
Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia.新型冠状病毒（2019-nCoV）引起肺炎爆发的分子诊断。
Clin Chem. 2020 Apr 1;66(4):549-555. doi: 10.1093/clinchem/hvaa029.